Real-world assessment of Fluorecare SARS-CoV-2 Spike Protein Test Kit

Real-world assessment of Fluorecare SARS-CoV-2 Spike Protein Test Kit

Since commercial SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2) antigen rapid detection tests (Ag-RDTs) display broad diagnostic efficiency, this study aimed to evaluate the clinical performance of Fluorecare SARS-CoV-2 Spike Protein Test Kit in a real-life scenario.

Bibliographic Details
Main Authors: Salvagno Gian Luca, Gianfilippi Gianluca, Pighi Laura, De Nitto Simone, Henry Brandon M., Lippi Giuseppe
Format: Article
Language:English
Published: De Gruyter 2021-05-01
Series:Advances in Laboratory Medicine
Subjects:
covid-19
diagnosis
immunoassay
laboratory medicine
sars-cov-2
Online Access:https://doi.org/10.1515/almed-2021-0041

Internet

https://doi.org/10.1515/almed-2021-0041

Similar Items